Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “GSK”

A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II DiabetesCompleted
NCT00675857Phase 2Updated Aug 24, 2010
Sponsor: Bellus Health Inc. - a GSK company
Diabetes Mellitus, Type 2 · Metabolic Syndrome X
Canada
European Study of 3APS in Mild to Moderate Alzheimer's Disease PatientsUnknown
NCT00217763Phase 3Updated Dec 10, 2007
Sponsor: Bellus Health Inc. - a GSK company
Alzheimer's Disease
Belgium, France, Germany, Italy, Netherlands +5 more
Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's DiseaseUnknown
NCT00314912Phase 3Updated Jul 16, 2007
Sponsor: Bellus Health Inc. - a GSK company
Alzheimer's Disease
United States
Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseUnknown
NCT00088673Phase 3Updated Feb 28, 2007
Sponsor: Bellus Health Inc. - a GSK company
Alzheimer Disease
United States, Canada
Study of the Safety and Efficacy of NC-503 in Secondary (AA) AmyloidosisCompleted
NCT00035334Phase 2, Phase 3Updated Feb 14, 2006
Sponsor: Bellus Health Inc. - a GSK company
Secondary (AA) Amyloidosis · Rheumatoid Arthritis · Nephrotic Syndrome · Familial Mediterranean Syndrome
United States, Finland, France, Israel, Italy +7 more
Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid AngiopathyCompleted
NCT00056238Phase 2Updated Jun 24, 2005
Sponsor: Bellus Health Inc. - a GSK company
Stroke · Neurologic Diseases, General
United States